810
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care?

, , &
Pages 353-355 | Published online: 10 Jan 2014

References

  • Facchetti F, Jones D, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Swerdlow S, Campo E, Harris NL et al. (Eds). IARC, Lyon, France, 145–147 (2008).
  • Petrella T, Facchetti F. Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009? Autoimmunity 43(3), 210–214 (2010).
  • Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv. Anat. Pathol. 16(6), 392–404 (2009).
  • Petrella T, Bagot M, Willemze R et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am. J. Clin. Pathol. 123(5), 662–675 (2005).
  • Petrella T, Meijer CJ, Dalac S et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am. J. Clin. Pathol. 122(2), 307–313 (2004).
  • Leroux D, Mugneret F, Callanan M et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood 99(11), 4154–4159 (2002).
  • Lucioni M, Novara F, Fiandrino G et al. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood 118(17), 4591–4594 (2011).
  • Jardin F, Ruminy P, Parmentier F et al. TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm. Br. J. Haematol. 153(3), 413–416 (2011).
  • Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH, Tensen CP. Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 109(4), 1720–1727 (2007).
  • Male HJ, Davis MB, McGuirk JP et al. Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission. Int. J. Hematol. 92(2), 398–400 (2010).
  • Ham JC, Janssen JJ, Boers JE, Kluin PM, Verdonck LF. Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm. J. Clin. Oncol. 30(8), e102–e103 (2012).
  • Krishnan S, Tan D, Hwang WY. Treatment of blastic plasmacytoid dendritic cell neoplasms with cord blood transplants. Clin. Adv. Hematol. Oncol. 9(7), 569–570 (2011).
  • Dietrich S, Andrulis M, Hegenbart U et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol. Blood Marrow Transplant. 17(8), 1250–1254 (2011).
  • Dalle S, Beylot-Barry M, Bagot M et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br. J. Dermatol. 162(1), 74–79 (2010).
  • Tsagarakis NJ, Kentrou NA, Papadimitriou KA et al.; Hellenic Dendritic Cell Leukemia Study Group. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk. Res. 34(4), 438–446 (2010).
  • Pagano L, Valentini CG, Di Paolantonio G et al. La leucemia a cellule dendritiche plasmacitoidi: risultati preliminari di uno studio retrospettivo multicentrico Italiano. Presented at: 43rd National Congress SIE–Italian Society of Hematology. Naples, Italy, 16–19 October 2011.
  • Jegalian AG, Buxbaum NP, Facchetti F et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica 95(11), 1873–1879 (2010).
  • Zuniga EI, McGavern DB, Pruneda-Paz JL, Teng C, Oldstone MB. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat. Immunol. 5(12), 1227–1234 (2004).
  • O’Garra A, Trinchieri G. Are dendritic cells afraid of commitment? Nat. Immunol. 5(12), 1206–1208 (2004).
  • Reineks EZ, Osei ES, Rosenberg A, Auletta J, Meyerson HJ. CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells. Cytometry B. Clin. Cytom. 76(4), 237–248 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.